© Asian Pacific Society of Respirology
Edited By: Peter Eastwood
Impact Factor: 3.345
ISI Journal Citation Reports © Ranking: 2014: 15/58 (Respiratory System)
Online ISSN: 1440-1843
1. MANUSCRIPT SUBMISSION
Thank you for your interest in Respirology. Please read the complete Author Guidelines carefully prior to submission, including the sections on copyright and publication fees. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. Once you have prepared your submission in accordance with the Guidelines, please use our manuscript preparation checklist before submitting your manuscript. Manuscripts should be submitted online at http://mc.manuscriptcentral.com/res
The Editor-in-Chief is:
Peter R. Eastwood
c/- School of Anatomy, Physiology and Human Biology
The University of Western Australia
35 Stirling Hwy
Crawley Western Australia 6009
Tel: +61 8 6488 8694
Fax:+61 8 6488 1550
We look forward to your submission.
2. EDITORIAL CONSIDERATIONS
Aims and Scope
Respirology is the official journal of the Asian Pacific Society of Respirology. It is the preferred English language journal of the Japanese Respiratory Society, the Thoracic Society of Australia and New Zealand and the Taiwanese Society of Pulmonary and Critical Care Medicine, and an official journal of the World Association of Bronchology and Interventional Pulmonology. The journal publishes original papers of international interest on laboratory and clinical research that are pertinent to respiratory biology and disease. Manuscripts on any topic within the field of respiratory medicine, including allied health; cell and molecular biology; epidemiology; immunology; pathology; pharmacology; physiology; intensive and critical care; paediatric respiratory medicine; bronchoscopy; interventional pulmonology and thoracic surgery are welcomed.
Effective 2015, Respirology will be published in electronic-only format and may be viewed at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1843/issues. Print subscriptions and single issue sales are available from Wiley’s Print-on-Demand Partner. To order online click here.
Editorial Review and Acceptance
Papers are published in Respirology in the approximate order of date of final acceptance under the following headings: Editorials,Invited Reviews, Reviews, Original Articles, Scientific Letters and Correspondences.
All submitted manuscripts, both unsolicited and invited, are reviewed before publication by multiple independent (i.e. independent from the author) qualified experts:
Original Articles, Scientific Letters and Systematic Reviews are pre-screened upon submission by a Deputy Editor who assesses whether the manuscript falls within the scope of Respirology and is suitable to send to external referees. A decision to reject a submitted manuscript without external review requires a confirmation by a second Deputy Editor. Approximately 30% of submitted manuscripts get rejected at this pre-screening stage. The other 70% are assigned to an expert Associate Editor who sends the manuscript to at least two external referees. Authors are encouraged to suggest preferred reviewers upon submission and the option to request non-preferred reviewers is also available. Respirology accepts approx. 20% of submitted Original Articles. Accepted articles require final approval from a Senior Editor before proceeding to publication.
Unsolicited Reviews are initially assessed by the Editor in Chief and, if approved for submission, are subsequently assigned to an appropriate Associate Editor for peer review by two external referees.
Invited Reviews are commissioned by the Editor in Chief and are assessed by at least one Associate Editor who can choose to involve one or more external referees.
Editorials and Correspondences are generally reviewed by the Editor in Chief only, who can involve external referees as required.
Respirology endorses the COPE Ethical Guidelines for Peer Reviewers.
Authors wishing to appeal a decision on their manuscript should contact the Editor in Chief (email@example.com) with a letter outlining the reasons for their appeal. The Editor in Chief will respond to all appeals in a timely manner with a final decision.
Disclaimer and reservations
The Editor-in-Chief and Editorial Board reserve the right to refuse any material for publication, and to accept manuscripts conditional upon changes in its contents and category of publication. Any final decision rests with the Editorial Board. The Publisher, Asian Pacific Society of Respirology, the Editorial Board and the Editors cannot be held responsible for errors or any consequences arising from the use of information contained in the journal.
Manuscripts concerning research supported in whole or in part by tobacco companies and associated institutes and organisations will not be considered for publication. Authors are expected to comply with strict ethical standards and for human research, conform to the provisions of the latest update of the WMA Declaration of Helsinki. Consent must be obtained from each patient after full explanation of the purpose, nature and risks of all procedures, and the research protocol must be approved by the Institutional Review Board or a suitably constituted Human Research Ethics Committee at the institution within which the work was undertaken. For retrospective studies using patient medical records, the Institutional Review Board or Ethics Committee must approve access to patient records and patient confidentiality must be maintained. For animal studies, approval from an appropriately constituted Animal Research Ethics Committee should be obtained. Statements regarding written informed consent and ethics approval, including the Ethics or Institutional Review Board approval number, must be included in the Methods section and proof of approval must be produced upon request. If ethics committee approval was not obtained or was not required, it should be stated in the Methods section of the manuscript.
Patient Consent and Confidentiality
Prior to submitting their manuscript, authors must ensure that the anonymity of every patient is respected by removing any detail that may lead to identification of a patient. If there is any possibility that a patient may be identified from the data presented in the submitted text, tables, figures or supplementary information, authors must obtain consent from the patient using the journal's Patient Consent Form and submit the completed form with their manuscript. In the circumstance that the patient is unable to provide consent (i.e. under 18, deceased, those who are unable to provide verbal or written consent, etc), authors must obtain consent from the patient's next of kin or legal representative.
Manuscripts should conform to the revised guidelines of the International Committee of Medical Journal Editors (ICMJE), published as ICMJE Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. These guidelines and the advice of the Editorial Board, Editorial Staff , Publisher and the Committee on Publication Ethics (COPE) will be used if matters of advice, dispute or contention arise in relation to publications and/or authors. In cases of suspected misconduct, Respirology follows COPE’s flowcharts and retraction guidelines.
Respirology requires the author to submit exclusively to the journal and will not accept original contributions containing significant portions of material published or submitted for publication elsewhere except for abstracts of no more than 400 words. Any material available through PubMed, Institutional websites, Pre-Print websites or other electronically accessible sources are considered to have been published. The Editors of Respirology reserve the right to refuse such contributions.
Authors are required to declare, in the cover letter, any overlap between the submitted manuscript and any previously published works or manuscripts submitted for publication elsewhere. This includes but is not limited to overlap with abstracts, manuscripts in another language as well as those based on the same data pool. Previously published material must be appropriately acknowledged and copies of related material should be provided upon request.
Respirology employs iThenticate software to detect plagiarism and, by submitting a manuscript to this journal, the authors accept that their manuscript will be screened for overlap with previously published works. We strongly advise authors to check their own work before submission to avoid rejection on those grounds.
For more information on ethical principles of academic publishing, please refer to Wiley’s ‘Best Practice Guidelines on Publication Ethics: A Publisher’s Perspective’.
Conflict of Interest and Authorship Statement
Respirology requires that all authors disclose any potential or actual conflict of interest (financial or other), or state the absence of such conflict of interest, as part of their manuscript. Respirology requests the corresponding author to take responsibility for the declaration of any conflict of interest and authorship by completing the Journal's Conflict of Interest and Authorship Declaration form. The completed form should be submitted online with the manuscript. In case of difficulty accessing or uploading this form, please contact the Editorial Office (firstname.lastname@example.org).
Authors should also complete the Author's Contribution Form (for up to 10 authors, use this form; for more than 10 authors or joint authorship as explained below, use this form) and upload it with their manuscript. All persons listed as authors should qualify for authorship as defined by the ICMJE ,i.e. authorship requires- (i) substantial contributions to: the conception or design of the work, the acquisition, analysis or interpretation of data for the work; (ii) drafting the work or revising it critically for important intellectual content; and (iii) final approval of the version to be published. All persons qualifying for these requirements should be listed as authors. No more than ten authors should be listed for any submission unless approved by the Editor in Chief. In addition, Respirology requires one author to act as guarantor for the study and this person is accountable for all aspects of the work and ensures that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
In exceptional circumstances, the Editor in Chief will accept equal first and last authorship and justification must be provided on the title page and on this Author's Contribution form. There can only be one corresponding author and this person is solely responsible for (i) communicating with the journal and managing communication between co-authors; (ii) including all qualifying authors in the author list and getting their approval for submission of the manuscript and the order in which the authors are listed (iii) distributing the proofs to all co-authors and returning all proof corrections to the journal office; (iv) responding to any queries regarding the published paper.
Use of Copyrighted Materials
Previously published material such as figures, tables, photographs, survey instruments and questionnaires may only be reproduced in Respirology with the specific permission of the copyright holder, which for figures, tables and photographs is usually with the publisher rather than the original author. The relevant figure legend or table caption should identify the source of the material and state that it is used with permission, and the full reference should be provided in the reference list. Please ensure that permission is obtained for both printed and electronic media dissemination.
Authors should be aware that many questionnaires or survey instruments are copyrighted, in order to maintain their integrity. The copyright conditions often require permission to be obtained from the copyright holder prior to any use of the instrument in research, and prohibit changes to the content, language and/or format of the instrument without specific permission from the copyright holder.It is the responsibility of the authors to verify whether a questionnaire or survey instrument is subject to any copyright restrictions, and to obtain written permission for its use prior to commencement of the research. Permission for use of validated instruments in research may be required by copyright holders even if the instrument has previously been published, or is available for use in clinical practice. Authors should be aware that unauthorised versions of well-known questionnaires may often be found online. If there is any doubt, the original author of the instrument should be contacted for clarification, prior to commencement of the research.
Respirology reserves the right to request written evidence that the authors obtained permission to use or reproduce any copyright material. Fees associated with the use of reproduction of copyrighted material are to be covered by the authors.
Respirology requires all clinical trials to be registered. The site of registration and the reference number must be stated at the end of the Abstract and in the Methods section of the manuscript. Respirology accepts registration in any of the primary registries of the WHO International Clinical Trials Registry Platform or in ClinicalTrials.gov . The majority of these registries are free to register.
According to ICMJE Recommendations, clinical trials commenced after 1 July 2005 must be registered in a public trials registry prior to the enrolment of the first participant for the manuscript to be considered for publication. Since 1 July 2008, the ICMJE has adopted the WHO definition of a clinical trial as “any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes”. Health-related interventions are those used to modify a biomedical or health-related outcome, e.g. drugs, surgical procedures, devices, behavioural treatments, dietary interventions, quality improvement interventions, process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants including pharmacokinetic measures and adverse events. Purely observation studies do not require registration.
Respirology accepts retrospective registration of clinical trials commenced before 1 July 2005. Retrospective registration of clinical trials commenced after 1 July 2005 is accepted in exceptional circumstances only, and on the condition that (i) the registration process is completed before manuscript submission, and (ii) the Methods section states the registration date and reason for late registration.
Respirology does not consider results posted in the same primary clinical trials registry in which the initial registration resides as prior publication, but requires authors to disclose all posting in registries of results of the same or closely related work.
Respirology endorses the CONSORT (Consolidated Standards of Reporting Trials) statement for reporting of randomized controlled trials. Manuscripts presenting clinical trial results should conform to the CONSORT statement, comply with the CONSORT checklist and include a CONSORT flow diagram as the first figure of the manuscript. Authors should also include a copy of the checklist as part of the submission and indicate which checklist items have been implemented where in the manuscript.
4. MANUSCRIPT CATEGORIES AND WORD LENGTH
Respirology encourages the submission of manuscripts focusing on clinical or laboratory research in areas relevant to the practice of respiratory medicine. Original articles must not be longer than 2500 words, excluding the abstract (maximum 250 words), references (maximum 50), table and figure legends. Longer manuscripts, unless justified in the covering letter, may be returned to the authors for reduction before being considered for peer review.
Editorials and Invited Reviews
Editorials and invited reviews are generally commissioned by the Editor-in-Chief. Author guidelines, including word counts, for editorials and invited reviews will be provided by the Editorial Office at the time of invitation. Invited papers are subject to the same review process as submissions.
Unsolicited review articles may only occasionally be considered if they cover a novel aspect of a relevant and timely topic of strong interest to readers of Respirology. Before submitting an unsolicited review, authors must contact the Editorial Office (email@example.com) and provide the following information for the Editor's consideration: (1) an abstract; (2) an outline of the manuscript including subheadings; (3) a paragraph describing the importance of the proposed review and highlighting the novel aspects compared to previously published reviews (4) an explanation of the review's relevance to the readership of Respirology, and (5) a short CV for each of the authors including any previous publications on the same topic as proof of the authors' track record in the field. Reviews submitted online without the pre-approval from the Editor-in-Chief will be declined immediately. Author guidelines, including word counts, for unsolicited reviews will be provided by the Editorial Office at the time of pre-approval. Unsolicited reviews are subject to external peer review and approval to submit doesn’t guarantee acceptance.
Respirology offers authors of review articles the opportunity to submit a case report to the Open Access journal Respirology Case Reports at the same time as submitting their review article to Respirology. The complementary case report should describe a clinical case which translates the content of the review article. If accepted, the case report and review article will be published simultaneously in the respective journals and electronically linked. The case report should comply with the Author Guidelines of Respirology Case Reports and is subject to the article publication charges of Respirology Case Reports.
Systematic Reviews and Meta-Analyses
Systematic reviews may or may not use statistical methods (meta-analysis) to analyze and summarize the results of the included studies. Respirology has endorsed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement, as described in the PRISMA Explanatory and Elaboration document. It recommends the use of its checklist and flow diagram as a guide to a systematic review with or without a meta-analysis approach (www.prisma-statement.org). Respirology requires authors to include a similar flow chart as part of the manuscript, and a copy of the checklist as part of the submission. Authors must indicate in the copy of the checklist which items have been implemented in the manuscript. Taking the time to ensure the review meets these basic reporting needs will improve the manuscript and potentially enhance its chances for eventual publication.
Authors of meta-analyses of observational studies must follow the Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guidelines and checklist, and include as part of their submission a copy of the checklist indicating the items that have been implemented.
Scientific Letters are brief reports that fall within the scope of Respirology and are of particular interest to its readership, containing new but insufficient scientific data to qualify as Original Article. This may include preliminary study outcomes, audits and articles that describe new methodologies or techniques. Respirology accepts and publishes very few Scientific Letters per year, and priority is given only to studies with a very high degree of novelty and interest. Scientific Letters should contain no more than 1200 words, one figure or table, and 15 references. The use of subheadings and supplementary information is not permitted. An unstructured abstract of maximum 75 words should also be included.
Respirology no longer accepts the submission of case reports. Instead, case reports can be submitted to Respirology Case Reports, the official Open Access case reports journal of the Asian Pacific Society of Respirology:
These are usually letters regarding articles published in Respirology. Letters must be fewer than 500 words. Author(s) of the article commented on may be invited to respond. Respirology reserves the right to accept or reject letters for publication, and may amend or extract text without misrepresenting the writer’s views.
5. PREPARATION OF THE MANUSCRIPT
English Expression and Manuscript Style
All contributions should be written in English and spelling should conform to the Concise Oxford English Dictionary. The Editors reserve the right to return manuscripts to the author for English language editing prior to external peer review. If necessary, Respirology may only consider the manuscript after it has been professionally edited at the author's expense. Visit http://wileyeditingservices.com to learn about the options. In addition, the Editors and Publisher reserve the right to modify typescripts of accepted manuscripts to eliminate ambiguity and repetition and to improve communication between author and reader. In following this practice the scientific content and message will not be changed. In case of extensive alterations, the manuscript will be returned to the author for revision and/or approval before publication.
Respirology no longer accepts the use of the eponyms ‘Clara cell’, ‘Clara cell secretory protein’ and ‘Wegener’s granulomatosis’ and will replace these terms with ‘club cell’, ‘club cell secretory protein’ and ‘granulomatosis with polyangiitis’ respectively. The old eponyms will be used in parentheses until the end of 2014. Further background information about this change in terminology can be found in the following publications:
*Winkelmann A, Noack T. The Clara cell: a “Third Reich eponym”? Eur Resp J. 2010;36: 722-7.
*Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts R. Granulomatosis with polyangiitis (Wegener’s): an alternative name for Wegener's granulomatosis. Ann Rheum Dis. 2011;70: 704.
The use of abbreviations is discouraged except for standard abbreviations of units of measure. Abbreviations used must be defined in parentheses on first mention in the abstract and again in the body of the manuscript. If applicable, they must be re-defined in the figure legend or table caption. A list of used abbreviations including their definitions must be provided as part of the manuscript.
Statistical Methods and Hypothesis
Where appropriate, all original articles should state the hypothesis that is being tested and detail the statistical method that was used.
For advice on statistical reporting, Respirology encourages authors to refer to the SAMPL guidelines: Lang T, Altman D. Basic statistical reporting for articles published in clinical medical journals: the SAMPL guidelines. In: Smart P, Maisonneuve H, Polderman A (eds.) Science Editors' Handbook, European Association of Science Editors, 2013.
Respirology uses the services of biostatisticians for the assessment of statistical methodology of selected manuscripts.
Parts of the Manuscript
Manuscripts should contain, in this order, a title page, summary at a glance (original articles only), abstract (see requirements below for each article type), key words, short title, text of the manuscript, acknowledgements, references, tables,and figure legends. Please note that in addition to including this in the manuscript, the title, abstract, names of the authors and their affiliations, short title and key words will have to be entered upon submission of the manuscript in ScholarOne Manuscripts.
The title page should include the title and all authors' full names, degrees and affiliations. The contact address, fax number and email for the corresponding author must also be provided. The word count for the abstract and text (without references, tables or figure legends) should also be provided on the title page.
Summary at a Glance
For Original Articles only, authors should provide a ‘Summary at a Glance’ that briefly states, in less than 50 words, what is being tested and what the presented study adds to the literature.
Original Articles: Concise abstract of no more than 250 words which is structured as follows: Background and objective, Methods, Results and Conclusions. The abstract should not contain references or footnotes.
Reviews: An unstructured and concise abstract of no more than 250 words should be included. The abstract should not contain references or footnotes.
Scientific Letters: A concise abstract of no more than 75 words should be included.
Editorials and Correspondences: No abstract is required, please type N/A in the abstract box upon submission in ScholarOne Manuscripts.
Five key words, in alphabetical order below the abstract, must be supplied for indexing purposes, and should be selected from the Medical Subject Headings (MeSH) list provided by the US National Library of Medicine
A short title of fewer than 40 characters (including spaces) must be provided.
Original Articles should be arranged under the usual headings of Introduction, Methods, Results and Discussion.
Methods (including statistical methods used, study design, participant recruitment and sample collection) should be described in sufficient detail to make clear how the results were derived. The location (city, state, country) of manufacturers specified in the text should be provided. Generic names of drugs should be used. SI units should be used throughout, with few exceptions, e.g. blood pressure (mmHg). If monetary values are mentioned in the manuscript, the equivalence in US dollars should also be presented. When applicable, statements regarding Ethics Committee and Institutional Review Board approval, written informed consent and clinical trial registration must be included in this section. Authors are encouraged to submit descriptions of non-critical or previously published methods as online supporting information.
Acknowledgements of persons (including their affiliation) who made a significant contribution and who endorse the data and conclusions should be included. Acknowledgement of funding sources is required. Submissions containing research supported by NIH grants must include the grant number in their acknowledgements.
References should be cited in the text, tables and legends, using superscript Arabic numerals (after punctuation marks where appropriate) in the order in which they first appear in the text. References should be limited to 50, typed doubled-spaced and numbered consecutively. All authors should be listed. Titles of journals should be abbreviated in the reference list according to the style used in Index Medicus. Journal issue numbers should not be quoted.
Reference formatting and punctuation should conform to the Journal style which is based on the Vancouver system.
Standard journal article
1 Lahita R, Kluger J, Drayer DE, Koffler D, Reidenberg MM. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. N. Engl. J. Med. 1979; 301: 1382–5.
Books and other monographs
2 Cade JF, Pain MCF. Essentials of Respiratory Medicine. Blackwell Science, Oxford, 1988.
3 Colby VT, Carrington CB. Infiltrative lung disease. In: Thurlbeck WM (ed.) Pathology of the Lung. Thieme Medical Publishers, New York, 1988; 198–213.
4 World Health Organisation, 3 July 2003. Update 94: Preparing for the Next Influenza Season in a World Altered by SARS. http://www.who.International/csr/disease/ inﬂuenza/sars. Accessed: 15 September 2003.
Online Article not yet published in an issue
An online article that has not yet been published in an issue (therefore has no volume, issue or page numbers) can be cited by its Digital Object Identifier (DOI). The DOI will remain valid and allow an article to be tracked even after its allocation to an issue.
5 Walker J, Kelly PT, Beckert L. Airline policy for passengers requiring supplemental in-flight oxygen. Respirology 2009 doi 10.1111/j.1440-1843.2009.01521.x
Unpublished observations and personal communications should not be listed as references, but may be incorporated in the text and stated as such in parentheses. References to articles in a language other than English that do not have an English abstract should not be used.
Tables should be included in the main manuscript document (Word format), at the end of the document, with one table per page and each table accompanied by a descriptive caption at the top. Each table should be referred to in the text and numbered in the order of mention. Explanatory material should be placed in footnotes below the Table and not included in the heading. All non-standard abbreviations should be defined in the footnotes. Footnotes should be indicated by *, †, ‡, §. Statistical terms such as SD or SEM should be identified in headings. Use of the word-processing ‘Table’ function for creating tables is encouraged; otherwise, use only one Tab (not spaces) to separate each column in a table. Tables inserted as objects in the manuscript will not be accepted.
The number of tables should be kept to a minimum and tables presenting large collections of data should be avoided. We encourage authors to make use of online supporting information where possible.
Legends should be supplied on a separate page in the manuscript file and should not appear as part of the figure files. Each figure should be referred to in the text and numbered in the order of mention. Symbols, arrows and numbers or letters used to identify parts of illustrations should be identified and explained in the legend. The description in the legend should be sufficient for the reader to interpret the figure without reference to the text.
Figures and Electronic Art
Manuscript submissions containing figures that do not adhere to the requirements and specifications outlined in this section will be returned to the authors for corrections prior to peer review.
Each figure must be submitted as a separate file and should not be embedded in the manuscript text file. All figures must be saved in EPS or TIFF format with a minimum resolution of 300 dpi. Figures should be presented at actual size to fit a single column (81 mm width), double column (169 mm width) or intermediate column (118 mm width). Each figure and figure file is to be identified clearly with the figure number.
Figures should be sharp and authors should refer to http://authorservices.wiley.com/bauthor/illustration.asp for further details. Letters, numbers and symbols must be clear and legible and their size should be in scale with the figure. Use a sans serif font (preferably Arial), avoid using bold type, and use a consistent font type and size throughout all figures in the manuscript. Titles, keys and detailed explanations should be confined to legends and not included in the figures. All photomicrographs must have internal scale markers and legends must include the magnification and stain used. Photographs of persons must be retouched to make the subject unidentifiable, or be accompanied by written permission from the subject to use the photograph (see 'Patient Consent and Confidentiality' section for more information and Patient Consent Form).
Research images must not be retouched or altered in any way that may misrepresent information present in the original image. The following four basic guidelines for handling image data have been developed by The Rockefeller University Press and are available on the website of the Council of Science Editors: (1) No specific feature within an image may be enhanced, obscured, moved, removed, or introduced; (2) Adjustments of brightness, contrast, or colour balance are acceptable if they are applied to the whole image and as long as they do not obscure, eliminate, or misrepresent any information present in the original; (3) The grouping of images from different parts of the same gel, or from different gels, fields, or exposures must be made explicit by the arrangement of the figure (e.g. dividing lines) and in the text of the figure legend; (4) If the original data cannot be produced by an author, acceptance of the manuscript may be revoked. Respirology randomly checks submitted and published papers for image manipulation. The original gel or blot images, from which parts have been used in arrangements, should be uploaded as supporting documents to allow composite image assessment.
The number of figures should be kept to a minimum and figures with more than four panels should be avoided. We encourage authors to make use of the supplementary information where possible.
There is no charge for publishing colour figures.
Images for the Journal Cover
Each electronic issue of Respirology features cover images selected from the papers published in the same issue. Authors are encouraged to submit suitable high-quality illustrations for consideration for cover illustration even if they do not appear in the actual article. The illustrations should be accompanied by a short explanatory legend, be submitted as supporting documents and have the word “cover” in the name of the files. Colour illustrations will be included on the cover free of charge for the author. Illustrations for the cover should comply with the requirement for figures as described above.
Supplementary information (e.g. non-critical methods, figures, tables and video material) can be submitted provided it is pertinent to the manuscript. If the manuscript is accepted for publication, supplementary material can be made available as a link to the published article. Supplementary information should be labelled sequentially Figure S1, Table S1, and so on and should be referred to in the text as “Supplementary Figure S1, Supplementary Table S1, etc”. Supplementary information should comply with Respirology's 'Manuscript structure and formatting' guidelines outlined above. Please note that supplementary information will be refereed but will not be copyedited, or proofread by the Journal staff or the Publisher. It is the responsibility of the authors to ensure the accuracy of the contents. Information on submission of supplementary information is available at
6. SUBMISSION REQUIREMENTS
• A cover letter containing an authorship statement should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file.
• The cover letter must include the following sections: (1) introductory sentence with manuscript title and author names, (2) paragraph outlining (in less than five sentences) why the work described in the manuscript is important, novel and suitable for publication in Respirology, and (3) a final paragraph outlining any special notes related to word count, ethics approval, patient consent, conflict of interest, relationship with recent research submitted elsewhere for publication and copyright.
• One Word file needs to be submitted, including: The title page and all parts of the text in the sequence indicated in the section 'Parts of the manuscript', including tables and figure legends but excluding figures which should be supplied separately.
• Manuscripts are to be typed double-spaced (including references, tables, figure legends and footnotes), in 12-point type, on A4 size paper with 3-cm margins at the top and the left-hand side of the pages and must be in Word (doc or docx) format only (pdf cannot be accepted and will be returned to the author for conversion). All pages should be numbered consecutively beginning with the title page.
• Each figure should be supplied as a separate file, with the figure number incorporated in the file name.
7. PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper. More details on the copyright and licencing options for the journal appear below.
Wiley’s Author Services
Author Services enables authors to track their article through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://www.authorservices.wiley.com/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
After acceptance of the manuscript, the corresponding author (as listed on the title page of the manuscript) will be charged a publication fee. Authors must agree to pay the fee upon submission of their manuscript and payment must be finalised prior to the manuscript being published. Correspondences and invited papers are excluded from this fee. Depending on the GDP per capita of the corresponding author's country of residence, the fee is US$300, US$150 or US$50 per manuscript. Please refer to this form for the publication fee per country. Authors should contact the Editorial Office (firstname.lastname@example.org) in case of hardship or special circumstance.
Once the paper has been typeset the corresponding author will receive an e-mail alert containing instructions on how to provide proof corrections to the article. It is therefore essential that a working e-mail address is provided for the corresponding author. Proofs should be corrected carefully; the responsibility for detecting errors lies with the author.
The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.
A PDF reprint of the article will be supplied free of charge to the corresponding author. Additional printed offprints may be ordered online for a fee. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: http://offprint.cosprinters.com/cos. If you have queries about offprints please e-mail: email@example.com.
Author Marketing Toolkit
The Wiley Author Marketing Toolkit provide authors with support on how to use social media, publicity, conferences, multimedia, email and the web to promote their article.
8. COPYRIGHT, LICENSING AND ONLINE OPEN
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.
Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under open access terms made available via Wiley OnlineOpen.
Standard Copyright Transfer Agreement: FAQs about the terms and conditions of the standard CTA in place for the journal, including standard terms regarding archiving of the accepted version of the paper, are available at: Copyright Terms and Conditions FAQs.
Note that in signing the journal’s licence agreement authors agree that consent to reproduce figures from another source has been obtained.
OnlineOpen – Wiley’s Open Access Option: OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access. Authors of OnlineOpen articles are permitted to post the final, published PDF of their article on their personal website, and in an institutional repository or other free public server immediately after publication. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND). To preview the terms and conditions of these open access agreements please visit the Copyright Terms and Conditions FAQs.
Funder Open Access and Self-Archiving Compliance: Please click here for more information on Wiley’s compliance with specific Funder Open Access and Self Archiving Policies, and click here for more detailed information specifically about Self-Archiving definitions and policies. Note to NIH Grantees. Pursuant to NIH mandate, Wiley will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see http://www.wiley.com/go/nihmandate.The NIH grant number must also be included in the acknowledgements section of the manuscript.
9. PUBLICATION FORMAT
The journal is published in electronic format only.
Guidelines for supplements to be published by Respirology can be obtained from the Editorial Office (firstname.lastname@example.org).
Author Guidelines updated 16 June 2015